Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-19
2005-04-19
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S556000
Reexamination Certificate
active
06881734
ABSTRACT:
The present invention relates to a method of treating disorders of the Central Nervous System (CNS) and other disorders in a mammal, including a human, by administering to the mammal a CNS-penetrant α7 nicotinic receptor agonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and a CNS-penetrant α7 nicotinic receptor agonist.
REFERENCES:
patent: WO 0192261 (2001-06-01), None
Coe Jotham Wadsworth
O'Donnell Christopher J.
O'Neill Brian Thomas
Ebel Eileen M.
Kifle Bruck
Ling Lorraine B.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Pharmaceutical composition for the treatment of CNS and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for the treatment of CNS and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment of CNS and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3400000